Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with kidney, bladder, breast, or lung cancer, confirmed by a doctor
- You are within about two weeks of starting a specific type of immunotherapy treatment (called a PD-1 or PD-L1 checkpoint inhibitor), either on its own or alongside other treatments
- You are 18 years old or older
- You are not currently pregnant and are not breastfeeding
- You have at least one basic everyday need that is unmet, such as access to food, transportation, or stable housing (this is checked using a short screening tool)
- You live in the New York metro area, including Long Island, New Jersey, Connecticut, or Pennsylvania
- You are able to speak English or Spanish
- You do not have severe psychiatric symptoms that would prevent you from completing surveys, interviews, or giving informed consent (confirm with trial site)
- You do not have a condition affecting memory or thinking, such as delirium or dementia, that would prevent you from giving informed consent or taking part in data collection (confirm with trial site)
Who may not be able to join:
- People who have not been diagnosed with kidney, bladder, breast, or lung cancer
- People who are pregnant or currently nursing
- People who are not starting the specific immunotherapy treatment within the required time window
- People who do not live in the specified areas near New York
- People who are unable to speak English or Spanish
- People with serious active psychiatric symptoms that would prevent meaningful participation (confirm with trial site)
- People with significant memory or thinking impairments, such as dementia or delirium (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Francesca Gany, MD, MS, Memorial Sloan Kettering Cancer Center
Phone: 646-888-8054
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Immune Checkpoint Inhibitors/ICI continuation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.